Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli (Q48036149)
scientific article published on 21 January 2006
Language:
Current Data About Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli
(P31) (Q13442814)
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

(P50) (Q40007133)
(P1545) 5
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

(Q60032286)
(P1545) 11
(P1932) Venkatachalam Udhayakumar
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018

(P304) 14-23
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

(P433) 1
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

(P478) 2
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

(P577) Saturday, January 21, 2006
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

(P921) (Q311383)

(Q25419)
(P887)

(P1433) (Q15755183)
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

(P1476) "Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli" (language: en)
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

(P2093) Zhiyong Zhou
(P1545) 1
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

Charles W Todd
(P1545) 2
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

Robert M Wohlhueter
(P1545) 3
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

April Price
(P1545) 4
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

Paul Schnake
(P1545) 6
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

Phillip Cullison Bonner
(P1545) 7
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

Amy M Martin
(P1545) 8
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

Ira F Goldman
(P1545) 9
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

Patricia De La Vega
(P1545) 10
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

Altaf A Lal
(P1545) 12
(P248)
(P698) 17012909
(P813) Wednesday, February 7, 2018
(P854) http://europepmc.org/abstract/MED/17012909

other details
description scientific article published on 21 January 2006

External Links
(P356) 10.4161/HV.2.1.2437
(P698) 17012909
(P5875) 6781997